13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001596452
申报总市值
US$1.3亿
US$1.3亿
49 檔
75.2%
在 Q4 2025 申报期间，Sivik Global Healthcare LLC（CIK: 0001596452）向美国 SEC 提交的 Form 13F 报告显示，其追踪之股票投资组合总市值达 US$1.3亿，共持有 49 个公开申报仓位。
Sivik Global Healthcare LLC 在 Q4 2025 进行了结构性的板块轮动与仓位换股。在开立 21 个全新仓位及加仓 5 档持股的同时，亦同步清仓 16 档并减仓 8 档标的。
在资产配置集中度方面，Sivik Global Healthcare LLC 的前 5 大核心持股（包含 XBI, PUT - SPY 100 @ 684 EXP 01/30/2026, 等）合计占整体申报市值的 75.2%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-科技型 | 7.96% | — | -10.00% | |
| 2 | ✓ | Put - Spy 100 @ 684 Exp 01/30/2026 | 股票-其他 | 5.94% | — | — | |
| 3 | ✓ | 股票-其他 | 4.95% | — | — | ||
| 4 | ✓ | Put - Spy 100 @ 681 Exp 01/30/2026 | 股票-其他 | 4.95% | — | — | |
| 5 | ✓ | 股票-其他 | 4.95% | — | — | ||
| 6 | ✓ | Put - Spy 100 @ 679 Exp 01/30/2026 | 股票-其他 | 4.95% | — | — | |
| 7 | ✓ | 股票-其他 | 4.95% | — | — | ||
| 8 | ✓ | 股票-其他 | 4.95% | — | — | ||
| 9 | ✓ | Put - Spy 100 @ 682 Exp 02/20/2026 | 股票-其他 | 4.95% | — | — | |
| 10 | LLY | Eli Lilly & Co | 股票-医疗保健 | 2.18% | — | -30.00% | |
| 11 | THC | Tenet Healthcare CORP | 股票-医疗保健 | 2.16% | — | +7.14% | |
| 12 | MCK | Mckesson CORP | 股票-医疗保健 | 2.14% | — | +28.57% | |
| 13 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 2.03% | — | -11.76% | |
| 14 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 2.02% | — | -14.29% | |
| 15 | CAH | Cardinal Health Inc | 股票-医疗保健 | 1.94% | — | -13.33% | |
| 16 | BSX | Boston Scientific CORP | 股票-医疗保健 | 1.94% | — | — | |
| 17 | VRTX | Vertex Pharmaceuticals Inc | 股票-医疗保健 | 1.81% | — | -1.64% | |
| 18 | UHS | Universal Health Services-b | 股票-医疗保健 | 1.77% | — | — | |
| 19 | COR | Cencora Inc | 股票-医疗保健 | 1.76% | — | -10.00% | |
| 20 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 1.64% | — | -23.08% | |
| 21 | EHC | Encompass Health CORP | 股票-医疗保健 | 1.54% | — | +42.86% | |
| 22 | DHR | Danaher CORP | 股票-医疗保健 | 1.53% | — | -34.29% | |
| 23 | ABT | Abbott Laboratories | 股票-医疗保健 | 1.45% | — | +6.67% | |
| 24 | A | Agilent Technologies Inc | 股票-医疗保健 | 1.38% | — | +6.06% | |
| 25 | ABBV | Abbvie Inc | 股票-医疗保健 | 1.33% | — | — | |
| 26 | SYK | Stryker CORP | 股票-医疗保健 | 1.33% | — | — | |
| 27 | MDT | Medtronic plc | 股票-医疗保健 | 1.25% | — | -25.00% | |
| 28 | MTD | Mettler-toledo International | 股票-医疗保健 | 1.21% | — | — | |
| 29 | SNN | Smith & Nephew PLC -spon Adr | 股票-其他 | 1.19% | — | -21.88% | |
| 30 | RGEN | Repligen CORP | 股票-医疗保健 | 1.19% | — | -9.09% | |
| 31 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 1.15% | — | — | |
| 32 | BDX | Becton Dickinson And Co | 股票-医疗保健 | 1.13% | — | — | |
| 33 | HUM | Humana Inc | 股票-医疗保健 | 1.11% | — | -40.00% | |
| 34 | NVO | Novo-nordisk A/s-spons Adr | 股票-医疗保健 | 1.11% | — | — | |
| 35 | AZNN | Astrazeneca Plc-spons Adr | 股票-其他 | 1.07% | — | — | |
| 36 | BIO | Bio-rad Laboratories-a | 股票-医疗保健 | 1.06% | — | +9.09% | |
| 37 | BIIB | Biogen Inc | 股票-医疗保健 | 1.02% | — | — | |
| 38 | GMED | Globus Medical Inc - A | 股票-医疗保健 | 1.01% | — | — | |
| 39 | MRK | Merck & Co. Inc. | 股票-医疗保健 | 0.92% | — | — | |
| 40 | SGRY | Surgery Partners Inc | 股票-其他 | 0.90% | — | -9.09% | |
| 41 | GILD | Gilead Sciences Inc | 股票-医疗保健 | 0.89% | — | — | |
| 42 | BRKR | Bruker CORP | 股票-医疗保健 | 0.89% | — | +8.33% | |
| 43 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 0.87% | — | — | |
| 44 | GEHC | GE Healthcare Technology | 股票-医疗保健 | 0.83% | — | +40.00% | |
| 45 | SEM | Select Medical Holdings CORP | 股票-其他 | 0.82% | — | +8.57% | |
| 46 | TECH | Bio-techne CORP | 股票-医疗保健 | 0.77% | — | — | |
| 47 | CGON | Cg Oncology Inc | 股票-其他 | 0.42% | — | — | |
| 48 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 0.37% | — | — | |
| 49 | ALNY | Alnylam Pharmaceuticals Inc | 股票-医疗保健 | 0.35% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | +0.7% | -10.00% | 减仓 |
| 2 | MCK | Mckesson CORP | +0.6% | +28.57% | 加仓 |
| 3 | BRKR | Bruker CORP | +0.3% | +8.33% | 加仓 |
| 4 | GEHC | GE Healthcare Technology | +0.3% | +40.00% | 加仓 |
| 5 | EHC | Encompass Health CORP | +0.3% | +42.86% | 加仓 |
| 6 | CAH | Cardinal Health Inc | +0.2% | -13.33% | 减仓 |
| 7 | VRTX | Vertex Pharmaceuticals Inc | +0.2% | -1.64% | 减仓 |
| 8 | SEM | Select Medical Holdings CORP | +0.2% | +8.57% | 加仓 |
| 9 | MDT | Medtronic plc | -0.4% | -25.00% | 减仓 |
| 10 | DHR | Danaher CORP | -0.5% | -34.29% | 减仓 |
| 11 | SGRY | Surgery Partners Inc | -0.5% | -9.09% | 减仓 |
| 12 | SNN | Smith & Nephew PLC -spon Adr | -0.5% | -21.88% | 减仓 |
| 13 | HUM | Humana Inc | -0.8% | -40.00% | 减仓 |
| 14 | ✓ | Put - Spy 100 @ 684 Exp 01/30/2026 | — | NEW | 新建仓 |
| 15 | ✓ | Put - Spy 100 @ 645 Exp 10/31/2025 | — | EXIT | 清仓 |
| 16 | ✓ | — | NEW | 新建仓 | |
| 17 | ✓ | Put - Spy 100 @ 679 Exp 01/30/2026 | — | NEW | 新建仓 |
| 18 | ✓ | — | NEW | 新建仓 | |
| 19 | ✓ | — | NEW | 新建仓 | |
| 20 | ✓ | — | NEW | 新建仓 | |
| 21 | ✓ | Put - Spy 100 @ 682 Exp 02/20/2026 | — | NEW | 新建仓 |
| 22 | ✓ | Put - Spy 100 @ 681 Exp 01/30/2026 | — | NEW | 新建仓 |
| 23 | ✓ | Put - Spy 100 @ 639 Exp 10/31/2025 | — | EXIT | 清仓 |
| 24 | ✓ | Put - Spy 100 @ 659 Exp 11/21/2025 | — | EXIT | 清仓 |
| 25 | ✓ | Put - Spy 100 @ 660 Exp 11/21/2025 | — | EXIT | 清仓 |
| 26 | ✓ | Put - Spy 100 @ 655 Exp 10/31/2025 | — | EXIT | 清仓 |
| 27 | ✓ | Put - Spy 100 @ 659 Exp 10/31/2025 | — | EXIT | 清仓 |
| 28 | ✓ | Put - Spy 100 @ 660 Exp 10/31/2025 | — | EXIT | 清仓 |
| 29 | ✓ | Put - Spy 100 @ 658 Exp 10/31/2025 | — | EXIT | 清仓 |
| 30 | ✓ | Put - Spy 100 @ 635 Exp 10/31/2025 | — | EXIT | 清仓 |
| 31 | JNJ | Johnson & Johnson | — | EXIT | 清仓 |
| 32 | MTD | Mettler-toledo International | — | NEW | 新建仓 |
| 33 | CI | THE Cigna Group | — | EXIT | 清仓 |
| 34 | ZBH | Zimmer Biomet Holdings Inc | — | EXIT | 清仓 |
| 35 | WST | West Pharmaceutical Services | — | EXIT | 清仓 |
| 36 | BDX | Becton Dickinson And Co | — | NEW | 新建仓 |
| 37 | NVO | Novo-nordisk A/s-spons Adr | — | NEW | 新建仓 |
| 38 | DGX | Quest Diagnostics Inc | — | EXIT | 清仓 |
| 39 | AZNN | Astrazeneca Plc-spons Adr | — | NEW | 新建仓 |
| 40 | BIIB | Biogen Inc | — | NEW | 新建仓 |
| 41 | GMED | Globus Medical Inc - A | — | NEW | 新建仓 |
| 42 | MRK | Merck & Co. Inc. | — | NEW | 新建仓 |
| 43 | GILD | Gilead Sciences Inc | — | NEW | 新建仓 |
| 44 | EW | Edwards Lifesciences CORP | — | NEW | 新建仓 |
| 45 | LH | Labcorp Holdings Inc | — | EXIT | 清仓 |
| 46 | TECH | Bio-techne CORP | — | NEW | 新建仓 |
| 47 | STVN | Stevanato Group S.p.A. | — | EXIT | 清仓 |
| 48 | CGON | Cg Oncology Inc | — | NEW | 新建仓 |
| 49 | ARGX | Argenx Se - Adr | — | NEW | 新建仓 |
| 50 | ALNY | Alnylam Pharmaceuticals Inc | — | NEW | 新建仓 |
根据 SEC 官方 Form 13F 申报备案，Sivik Global Healthcare LLC 在 Q4 2025 季度的美股持仓总市值约为 US$1.3亿，共申报了 49 个公开持股仓位。
在 Q4 2025 季度，Sivik Global Healthcare LLC 按市值排列的前三大核心持股分别为：XBI (8.0%)、PUT - SPY 100 @ 684 EXP 01/30/2026 (5.9%)、 (5.0%)。其中最大持股仓位 XBI 占据整体投资组合约 8.0% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
PUT - SPY 100 @ 684 EXP 01/30/2026
市值: US$2045.8万
本季最大获利了结 / 清仓标的
PUT - SPY 100 @ 645 EXP 10/31/2025
前期市值: US$1998.5万
在 Q4 2025 季度中，Sivik Global Healthcare LLC 共进行了 50 项持仓异动，包含新建仓 21 个仓位、加仓 5 个仓位、减仓 8 个仓位以及清仓 16 个仓位。 其中最大新建仓标的为 PUT - SPY 100 @ 684 EXP 01/30/2026。 本季清仓仓位包含 PUT - SPY 100 @ 645 EXP 10/31/2025。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。